Conversely, stableknockdown of Nanog using shRNA, which did not alter cell proliferation (Suppl.Fig. S1D), in sarcoma spheroid cellsresulted in decreased expression of CD133 as determined by western blot andimmunofluorescence (Suppl. This evidence concerns the gene NANOG and sarcoma.